Think Bioscience, founded in 2019, operates at the forefront of the Biotechnology, Health and Wellness, and Life Sciences industries. Based in the United States, the company is innovating the field under the slogan, "Natural Medicines Reimagined."
With a mission to leverage microbes in drug development, Think Bioscience focuses on "using microbes to drug the undruggable," a potentially transformative approach within the biotech landscape. This strategy positions the company to disrupt traditional pharmaceutical models and tackle targets previously considered unreachable.
As of May 7, 2024, Think Bioscience secured a Seed Round investment totaling $6.00 million from YK Bioventures. The funding injection signals investor confidence in its unique approach and marks a significant step towards scaling its innovations. Investors should anticipate that the company's pioneering techniques and recent financial backing will catalyze further advancements and commercialization prospects.